Joseph Hibbeln is a Psychiatry physician affiliated with National Institutes of Health. OpenAlex indexes 214 publications with 16,950 citations (h-index 67); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1430 Highland Dr
Silver Spring, MD 209101524
Telephone
301-785-4241Registry record last updated 19 Nov 2019.
Clinical trials
- Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Sponsor: Medical University of South Carolina
- Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study
Sponsor: Medical University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20233 payments
- Teva Pharmaceuticals USA, Inc.Program year20232 payments
- Janssen Pharmaceuticals, IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine17.5%Clonazepam57%Lorazepam43%Part D<11 patientsSNRI17.5%Duloxetine Hcl53%Venlafaxine Hcl Er47%Part D<11 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Relationships between seafood consumption during pregnancy and childhood and neurocognitive development: Two systematic reviews
Prostaglandins Leukotrienes and Essential Fatty Acids
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”